January 19, 2022

Xcellbio announces $27.5 million Series B financing

SAN FRANCISCO, Jan. 19, 2022 — Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of innovative technologies and platforms designed to further the research, development, and manufacturing of cell and gene therapies, today announced $27.5 million in Series B financing led by Casdin Capital. Also participating in this financing are new investors Dynamk Capital, Formic Ventures, and Labcorp, as well as existing investors HBM Genomics and Viking Global Investors. In connection with the financing, Shaun Rodriguez, PhD, Director of Life Science Research at Casdin Capital, will join the Xcellbio board of directors.
Read more »
Routine testing for body fever on population during COVID-19 crisis

Demystifying “Flurona”: Dual Viral Infection Is More Common Than You May Think

Since the start of the year, you’ve undoubtedly been hearing more and more about “Flurona.” You may be asking yourself, “Is this even possible? Why are we seeing this now? What can I do to protect myself and my loved ones?” 

January 18, 2022

MentorcliQ Names Labcorp’s Mary Schlegel as its first “Diversity ChangeMaker of the Year”

COLUMBUS, Ohio, Jan. 18, 2022 — Today, MentorcliQ, the leader in employee mentoring software, announced Mary Schlegel, learning and development manager at leading global life sciences company Labcorp, as the MentorcliQ 2021 Diversity ChangeMaker of the Year. The award is presented to an individual who has leveraged mentoring within their organization to create a greater sense of acceptance, belonging and community for all employees. The winner has also helped to foster positive social change and embodies the idea that all workplaces should promote diversity, equity, and inclusion (DEI) for the benefit of everyone.
Read more »